Daniel J. Moriarty

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.

John F. Brensike, R I Levy, S. F. Kelsey et al. · Circulation · 1984 · 680 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group Trial (E3205)

Madhur Garg, Fengmin Zhao, Joseph A. Sparano et al. · Journal of Clinical Oncology · 2017 · 82 citations

Medicine, Oncology, Radiation Oncology +17

National heart, lung, and blood institute type II coronary intervention study: Design, methods, and baseline characteristics

John F. Brensike, Sheryl F. Kelsey, Eugene R. Passamani et al. · Controlled Clinical Trials · 1982 · 45 citations

Medicine, Cardiology, Internal Medicine +14

GIANT MECKEL'S DIVERTICULUM IN A PREMATURE INFANT

Valmore F. Cross, Arthur J. Wendth, John J. Phelan et al. · American Journal of Roentgenology · 1970 · 18 citations

Medicine, Anatomy, Pediatrics +3

Secondary prevention and lipid lowering: Results and implications

Katherine M. Detre, Robert I. Levy, Sheryl F. Kelsey et al. · American Heart Journal · 1985 · 11 citations

Medicine, Chronic Disease Prevention, Preventive Medicine +13